Page last updated: 2024-09-05

ly 300502 and wb 4101

ly 300502 has been researched along with wb 4101 in 1 studies

Compound Research Comparison

Studies (ly 300502)	Trials (ly 300502)	Recent Studies (post-2010) (ly 300502)	Studies (wb 4101)	Trials (wb 4101)	Recent Studies (post-2010) (wb 4101)
6	0	0	477	1	34

Protein Interaction Comparison

Protein	Taxonomy	ly 300502 (IC50)	wb 4101 (IC50)
Alpha-1A adrenergic receptor	Homo sapiens (human)		0.001

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ballard, S; Blagg, J; Fox, D; Kenny, B	1

Reviews

1 review(s) available for ly 300502 and wb 4101

Article	Year
Pharmacological options in the treatment of benign prostatic hyperplasia. Journal of medicinal chemistry, 1997, Apr-25, Volume: 40, Issue:9 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship	1997

Article

Year

Pharmacological options in the treatment of benign prostatic hyperplasia.

Journal of medicinal chemistry, 1997, Apr-25, Volume: 40, Issue:9

Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship

1997